Whole exome studies (WES) have identified more than 30 variants in the ACE2 gene, potentially interfering with protein structure, stabilization and expression, and contributing to the high interindividual variability and susceptibility to COVID-19 (19). The gene discussed is ACE2; the disease is COVID-19.